Copyright Reports & Markets. All rights reserved.

Global Gadobutrol (CAS 138071-82-6) Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Gadobutrol (CAS 138071-82-6) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Gadobutrol (CAS 138071-82-6) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Gadobutrol (CAS 138071-82-6) Market Size Growth Rate by Type
    • 1.4.2 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
    • 1.4.3 Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
    • 1.4.4 Pharmacy Bulk Packages (30 mL and 65 mL)
  • 1.5 Market by Application
    • 1.5.1 Global Gadobutrol (CAS 138071-82-6) Market Size Growth Rate by Application
    • 1.5.2 Adults
    • 1.5.3 Children
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Gadobutrol (CAS 138071-82-6) Market Size, Estimates and Forecasts
    • 2.1.1 Global Gadobutrol (CAS 138071-82-6) Revenue 2015-2026
    • 2.1.2 Global Gadobutrol (CAS 138071-82-6) Sales 2015-2026
  • 2.2 Global Gadobutrol (CAS 138071-82-6), Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Gadobutrol (CAS 138071-82-6) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Gadobutrol (CAS 138071-82-6) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Gadobutrol (CAS 138071-82-6) Competitor Landscape by Players

  • 3.1 Gadobutrol (CAS 138071-82-6) Sales by Manufacturers
    • 3.1.1 Gadobutrol (CAS 138071-82-6) Sales by Manufacturers (2015-2020)
    • 3.1.2 Gadobutrol (CAS 138071-82-6) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Gadobutrol (CAS 138071-82-6) Revenue by Manufacturers
    • 3.2.1 Gadobutrol (CAS 138071-82-6) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Gadobutrol (CAS 138071-82-6) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Gadobutrol (CAS 138071-82-6) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Gadobutrol (CAS 138071-82-6) Revenue in 2019
    • 3.2.5 Global Gadobutrol (CAS 138071-82-6) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Gadobutrol (CAS 138071-82-6) Price by Manufacturers
  • 3.4 Gadobutrol (CAS 138071-82-6) Manufacturing Base Distribution, Product Types
    • 3.4.1 Gadobutrol (CAS 138071-82-6) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Gadobutrol (CAS 138071-82-6) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Gadobutrol (CAS 138071-82-6) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Gadobutrol (CAS 138071-82-6) Market Size by Type (2015-2020)
    • 4.1.1 Global Gadobutrol (CAS 138071-82-6) Sales by Type (2015-2020)
    • 4.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2015-2020)
    • 4.1.3 Gadobutrol (CAS 138071-82-6) Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Gadobutrol (CAS 138071-82-6) Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Type (2021-2026)
    • 4.2.3 Gadobutrol (CAS 138071-82-6) Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Gadobutrol (CAS 138071-82-6) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Gadobutrol (CAS 138071-82-6) Market Size by Application (2015-2020)
    • 5.1.1 Global Gadobutrol (CAS 138071-82-6) Sales by Application (2015-2020)
    • 5.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2015-2020)
    • 5.1.3 Gadobutrol (CAS 138071-82-6) Price by Application (2015-2020)
  • 5.2 Gadobutrol (CAS 138071-82-6) Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Gadobutrol (CAS 138071-82-6) Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Gadobutrol (CAS 138071-82-6) by Country
    • 6.1.1 North America Gadobutrol (CAS 138071-82-6) Sales by Country
    • 6.1.2 North America Gadobutrol (CAS 138071-82-6) Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Type
  • 6.3 North America Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Gadobutrol (CAS 138071-82-6) by Country
    • 7.1.1 Europe Gadobutrol (CAS 138071-82-6) Sales by Country
    • 7.1.2 Europe Gadobutrol (CAS 138071-82-6) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Type
  • 7.3 Europe Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Gadobutrol (CAS 138071-82-6) by Region
    • 8.1.1 Asia Pacific Gadobutrol (CAS 138071-82-6) Sales by Region
    • 8.1.2 Asia Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Type
  • 8.3 Asia Pacific Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Gadobutrol (CAS 138071-82-6) by Country
    • 9.1.1 Latin America Gadobutrol (CAS 138071-82-6) Sales by Country
    • 9.1.2 Latin America Gadobutrol (CAS 138071-82-6) Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Type
  • 9.3 Central & South America Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Gadobutrol (CAS 138071-82-6) by Country
    • 10.1.1 Middle East and Africa Gadobutrol (CAS 138071-82-6) Sales by Country
    • 10.1.2 Middle East and Africa Gadobutrol (CAS 138071-82-6) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Type
  • 10.3 Middle East and Africa Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bayer HealthCare Pharmaceuticals Inc.
    • 11.1.1 Bayer HealthCare Pharmaceuticals Inc. Corporation Information
    • 11.1.2 Bayer HealthCare Pharmaceuticals Inc. Description and Business Overview
    • 11.1.3 Bayer HealthCare Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.1.5 Bayer HealthCare Pharmaceuticals Inc. Related Developments
  • 11.2 SWAPNROOP DRUGS & PHARMACEUTICALS
    • 11.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Corporation Information
    • 11.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Description and Business Overview
    • 11.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.2.5 SWAPNROOP DRUGS & PHARMACEUTICALS Related Developments
  • 11.3 Manus Aktteva Biopharma LLP
    • 11.3.1 Manus Aktteva Biopharma LLP Corporation Information
    • 11.3.2 Manus Aktteva Biopharma LLP Description and Business Overview
    • 11.3.3 Manus Aktteva Biopharma LLP Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.3.5 Manus Aktteva Biopharma LLP Related Developments
  • 11.4 Jilin Tely Imp & Exp CO.,LTD
    • 11.4.1 Jilin Tely Imp & Exp CO.,LTD Corporation Information
    • 11.4.2 Jilin Tely Imp & Exp CO.,LTD Description and Business Overview
    • 11.4.3 Jilin Tely Imp & Exp CO.,LTD Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.4.5 Jilin Tely Imp & Exp CO.,LTD Related Developments
  • 11.5 JinYan Chemicals (ShangHai) Co., Ltd.
    • 11.5.1 JinYan Chemicals (ShangHai) Co., Ltd. Corporation Information
    • 11.5.2 JinYan Chemicals (ShangHai) Co., Ltd. Description and Business Overview
    • 11.5.3 JinYan Chemicals (ShangHai) Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.5.5 JinYan Chemicals (ShangHai) Co., Ltd. Related Developments
  • 11.6 BOC Sciences
    • 11.6.1 BOC Sciences Corporation Information
    • 11.6.2 BOC Sciences Description and Business Overview
    • 11.6.3 BOC Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 BOC Sciences Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.6.5 BOC Sciences Related Developments
  • 11.7 LGM Pharma
    • 11.7.1 LGM Pharma Corporation Information
    • 11.7.2 LGM Pharma Description and Business Overview
    • 11.7.3 LGM Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 LGM Pharma Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.7.5 LGM Pharma Related Developments
  • 11.8 Advanced Technology & Industrail Co., Ltd.
    • 11.8.1 Advanced Technology & Industrail Co., Ltd. Corporation Information
    • 11.8.2 Advanced Technology & Industrail Co., Ltd. Description and Business Overview
    • 11.8.3 Advanced Technology & Industrail Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.8.5 Advanced Technology & Industrail Co., Ltd. Related Developments
  • 11.9 MedKoo Biosciences, Inc.
    • 11.9.1 MedKoo Biosciences, Inc. Corporation Information
    • 11.9.2 MedKoo Biosciences, Inc. Description and Business Overview
    • 11.9.3 MedKoo Biosciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.9.5 MedKoo Biosciences, Inc. Related Developments
  • 11.1 Bayer HealthCare Pharmaceuticals Inc.
    • 11.1.1 Bayer HealthCare Pharmaceuticals Inc. Corporation Information
    • 11.1.2 Bayer HealthCare Pharmaceuticals Inc. Description and Business Overview
    • 11.1.3 Bayer HealthCare Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Products Offered
    • 11.1.5 Bayer HealthCare Pharmaceuticals Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Gadobutrol (CAS 138071-82-6) Market Estimates and Projections by Region
    • 12.1.1 Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Gadobutrol (CAS 138071-82-6) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Gadobutrol (CAS 138071-82-6) Sales Forecast (2021-2026)
    • 12.2.2 North America: Gadobutrol (CAS 138071-82-6) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Gadobutrol (CAS 138071-82-6) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Gadobutrol (CAS 138071-82-6) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Gadobutrol (CAS 138071-82-6) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Gadobutrol (CAS 138071-82-6) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Gadobutrol (CAS 138071-82-6) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Gadobutrol (CAS 138071-82-6) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Gadobutrol (CAS 138071-82-6) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Gadobutrol (CAS 138071-82-6) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Gadobutrol (CAS 138071-82-6) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Gadobutrol (CAS 138071-82-6) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Gadobutrol (CAS 138071-82-6) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Gadobutrol (CAS 138071-82-6) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Gadobutrol (CAS 138071-82-6) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Gadobutrol (CAS 138071-82-6) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Gadobutrol (CAS 138071-82-6) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Gadobutrol (CAS 138071-82-6) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Gadobutrol (CAS 138071-82-6) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Gadobutrol (CAS 138071-82-6) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Gadobutrol (CAS 138071-82-6) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Gadobutrol (CAS 138071-82-6) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gadobutrol (CAS 138071-82-6) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Gadobutrol (CAS 138071-82-6) market is segmented into
    Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
    Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
    Pharmacy Bulk Packages (30 mL and 65 mL)

    Segment by Application, the Gadobutrol (CAS 138071-82-6) market is segmented into
    Adults
    Children

    Regional and Country-level Analysis
    The Gadobutrol (CAS 138071-82-6) market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Gadobutrol (CAS 138071-82-6) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Gadobutrol (CAS 138071-82-6) Market Share Analysis
    Gadobutrol (CAS 138071-82-6) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gadobutrol (CAS 138071-82-6) business, the date to enter into the Gadobutrol (CAS 138071-82-6) market, Gadobutrol (CAS 138071-82-6) product introduction, recent developments, etc.

    The major vendors covered:
    Bayer HealthCare Pharmaceuticals Inc.
    SWAPNROOP DRUGS & PHARMACEUTICALS
    Manus Aktteva Biopharma LLP
    Jilin Tely Imp & Exp CO.,LTD
    JinYan Chemicals (ShangHai) Co., Ltd.
    BOC Sciences
    LGM Pharma
    Advanced Technology & Industrail Co., Ltd.
    MedKoo Biosciences, Inc.

    Buy now